190 related articles for article (PubMed ID: 38336780)
21. Dominant neoantigen verification in hepatocellular carcinoma by a single-plasmid system coexpressing patient HLA and antigen.
Chen P; Chen D; Bu D; Gao J; Qin W; Deng K; Ren L; She S; Xu W; Yang Y; Xie X; Liao W; Chen H
J Immunother Cancer; 2023 Apr; 11(4):. PubMed ID: 37076248
[TBL] [Abstract][Full Text] [Related]
22. Neoantigen identification strategies enable personalized immunotherapy in refractory solid tumors.
Chen F; Zou Z; Du J; Su S; Shao J; Meng F; Yang J; Xu Q; Ding N; Yang Y; Liu Q; Wang Q; Sun Z; Zhou S; Du S; Wei J; Liu B
J Clin Invest; 2019 May; 129(5):2056-2070. PubMed ID: 30835255
[TBL] [Abstract][Full Text] [Related]
23. Isolation of T cell receptors targeting recurrent neoantigens in hematological malignancies.
Tubb VM; Schrikkema DS; Croft NP; Purcell AW; Linnemann C; Freriks MR; Chen F; Long HM; Lee SP; Bendle GM
J Immunother Cancer; 2018 Jul; 6(1):70. PubMed ID: 30001747
[TBL] [Abstract][Full Text] [Related]
24. Proteogenomic identification of an immunogenic HLA class I neoantigen in mismatch repair-deficient colorectal cancer tissue.
Hirama T; Tokita S; Nakatsugawa M; Murata K; Nannya Y; Matsuo K; Inoko H; Hirohashi Y; Hashimoto S; Ogawa S; Takemasa I; Sato N; Hata F; Kanaseki T; Torigoe T
JCI Insight; 2021 Jul; 6(14):. PubMed ID: 34185709
[TBL] [Abstract][Full Text] [Related]
25. Mass spectrometric analysis of the HLA class I peptidome of melanoma cell lines as a promising tool for the identification of putative tumor-associated HLA epitopes.
Gloger A; Ritz D; Fugmann T; Neri D
Cancer Immunol Immunother; 2016 Nov; 65(11):1377-1393. PubMed ID: 27600516
[TBL] [Abstract][Full Text] [Related]
26. GNIFdb: a neoantigen intrinsic feature database for glioma.
Li W; Sun T; Li M; He Y; Li L; Wang L; Wang H; Li J; Wen H; Liu Y; Chen Y; Fan Y; Xin B; Zhang J
Database (Oxford); 2022 Feb; 2022():. PubMed ID: 35150127
[TBL] [Abstract][Full Text] [Related]
27. Early Kinetics of the HLA Class I-Associated Peptidome of MVA.HIVconsv-Infected Cells.
Ternette N; Block PD; Sánchez-Bernabéu Á; Borthwick N; Pappalardo E; Abdul-Jawad S; Ondondo B; Charles PD; Dorrell L; Kessler BM; Hanke T
J Virol; 2015 Jun; 89(11):5760-71. PubMed ID: 25810538
[TBL] [Abstract][Full Text] [Related]
28. Prediction and prioritization of neoantigens: integration of RNA sequencing data with whole-exome sequencing.
Karasaki T; Nagayama K; Kuwano H; Nitadori JI; Sato M; Anraku M; Hosoi A; Matsushita H; Takazawa M; Ohara O; Nakajima J; Kakimi K
Cancer Sci; 2017 Feb; 108(2):170-177. PubMed ID: 27960040
[TBL] [Abstract][Full Text] [Related]
29. Identification of HLA-A2-Restricted Mutant Epitopes from Neoantigens of Esophageal Squamous Cell Carcinoma.
Wang Z; Ran L; Chen C; Shi R; Dong Y; Li Y; Zhou X; Qi Y; Zhu P; Gao Y; Wu Y
Vaccines (Basel); 2021 Oct; 9(10):. PubMed ID: 34696226
[TBL] [Abstract][Full Text] [Related]
30. A proteogenomic approach to target neoantigens in solid tumors.
Verma A; Halder A; Marathe S; Purwar R; Srivastava S
Expert Rev Proteomics; 2020; 17(11-12):797-812. PubMed ID: 33491499
[TBL] [Abstract][Full Text] [Related]
31. Large-Scale Immunopeptidome Analysis Reveals Recurrent Posttranslational Splicing of Cancer- and Immune-Associated Genes.
Levy R; Alter Regev T; Paes W; Gumpert N; Cohen Shvefel S; Bartok O; Dayan-Rubinov M; Alon M; Shmueli MD; Levin Y; Merbl Y; Ternette N; Samuels Y
Mol Cell Proteomics; 2023 Apr; 22(4):100519. PubMed ID: 36828127
[TBL] [Abstract][Full Text] [Related]
32. Identification of neoantigens in oesophageal adenocarcinoma.
Nicholas B; Bailey A; McCann KJ; Wood O; Walker RC; Parker R; Ternette N; Elliott T; Underwood TJ; Johnson P; Skipp P
Immunology; 2023 Mar; 168(3):420-431. PubMed ID: 36111495
[TBL] [Abstract][Full Text] [Related]
33. Benchmarking Bioinformatics Pipelines in Data-Independent Acquisition Mass Spectrometry for Immunopeptidomics.
Shahbazy M; Ramarathinam SH; Illing PT; Jappe EC; Faridi P; Croft NP; Purcell AW
Mol Cell Proteomics; 2023 Apr; 22(4):100515. PubMed ID: 36796644
[TBL] [Abstract][Full Text] [Related]
34. Emerging potential of immunopeptidomics by mass spectrometry in cancer immunotherapy.
Minegishi Y; Haga Y; Ueda K
Cancer Sci; 2024 Apr; 115(4):1048-1059. PubMed ID: 38382459
[TBL] [Abstract][Full Text] [Related]
35. Systematic identification of personal tumor-specific neoantigens in chronic lymphocytic leukemia.
Rajasagi M; Shukla SA; Fritsch EF; Keskin DB; DeLuca D; Carmona E; Zhang W; Sougnez C; Cibulskis K; Sidney J; Stevenson K; Ritz J; Neuberg D; Brusic V; Gabriel S; Lander ES; Getz G; Hacohen N; Wu CJ
Blood; 2014 Jul; 124(3):453-62. PubMed ID: 24891321
[TBL] [Abstract][Full Text] [Related]
36. Characterization of CD8
Shinkawa T; Tokita S; Nakatsugawa M; Kikuchi Y; Kanaseki T; Torigoe T
Oncoimmunology; 2021 Jan; 10(1):1870062. PubMed ID: 33537174
[TBL] [Abstract][Full Text] [Related]
37. Approach for Identifying Human Leukocyte Antigen (HLA)-DR Bound Peptides from Scarce Clinical Samples.
Heyder T; Kohler M; Tarasova NK; Haag S; Rutishauser D; Rivera NV; Sandin C; Mia S; Malmström V; Wheelock ÅM; Wahlström J; Holmdahl R; Eklund A; Zubarev RA; Grunewald J; Ytterberg AJ
Mol Cell Proteomics; 2016 Sep; 15(9):3017-29. PubMed ID: 27452731
[TBL] [Abstract][Full Text] [Related]
38. Engineering Cell Lines for Specific Human Leukocyte Antigen Presentation.
Jin D; Loh KL; Shamekhi T; Ting YT; Lim Kam Sian TCC; Roest J; Ooi JD; Vivian JP; Faridi P
Methods Mol Biol; 2023; 2691():351-369. PubMed ID: 37355557
[TBL] [Abstract][Full Text] [Related]
39. dbPepNeo: a manually curated database for human tumor neoantigen peptides.
Tan X; Li D; Huang P; Jian X; Wan H; Wang G; Li Y; Ouyang J; Lin Y; Xie L
Database (Oxford); 2020 Jan; 2020():. PubMed ID: 32090262
[TBL] [Abstract][Full Text] [Related]
40. The major histocompatibility complex class I immunopeptidome of extracellular vesicles.
Synowsky SA; Shirran SL; Cooke FGM; Antoniou AN; Botting CH; Powis SJ
J Biol Chem; 2017 Oct; 292(41):17084-17092. PubMed ID: 28860189
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
